Embecta Corp

Затворен

СекторЗдравеопазване

4.42 26.65

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

3.51

Максимум

4.68

Ключови измерители

By Trading Economics

Приходи

-48M

-4.1M

Продажби

-39M

222M

P/E

Средно за сектора

1.928

68.51

EPS

0.27

Дивидентна доходност

16.48

Марж на печалбата

-1.849

Служители

1,850

EBITDA

-51M

45M

Препоръки

By TipRanks

Препоръки

Продай

12-месечна прогноза

-14.29% downside

Дивиденти

By Acuity

Дивидентна доходност

Средно за сектора

16.48%

2.29%

Следващи печалби

7.08.2026 г.

Следваща дата на дивидент

15.09.2026 г.

Следваща дата на екс-дивидент

27.08.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

-327M

221M

Предишно отваряне

-22.23

Предишно затваряне

4.42

Настроения в новините

By Acuity

72%

28%

308 / 340 Класиране в Healthcare

Embecta Corp Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

6.08.2026 г., 23:42 ч. UTC

Embecta Corp shares are higher in after-market hours, recovering from earlier lows. No specific news was identified to explain this movement.

5.08.2026 г., 22:36 ч. UTC

News

Embecta Corp faces a securities fraud class action lawsuit over misleading fiscal statements, contributing to a modest decline in after-market trading.

4.08.2026 г., 19:26 ч. UTC

Embecta Corp shares are higher during Tuesday's session, reaching a session high. No specific company news was identified to explain the upward movement.

3.08.2026 г., 20:03 ч. UTC

Embecta Corp shares are higher today, benefiting from positive investor sentiment in the health care supplies sector amid a rising broader market.

31.07.2026 г., 21:02 ч. UTC

Embecta Corp shares are lower in after-market hours, continuing a recent decline amid broader market concerns over inflation and rising interest rates.

30.07.2026 г., 21:02 ч. UTC

Embecta Corp shares are higher in after-market trading, amid positive market sentiment focused on corporate earnings despite geopolitical tensions and inflation concerns.

29.07.2026 г., 19:04 ч. UTC

Embecta Corp gains amid a strong Health Care Supplies sub-sector, despite pulling back from earlier session highs. Overall, shares are higher since Tuesday's close.

28.07.2026 г., 22:01 ч. UTC

Embecta Corp shares are higher in after-market hours, continuing a positive trend since Tuesday's close. No specific news was identified to explain the movement.

27.07.2026 г., 18:03 ч. UTC

Embecta Corp shares are trading higher, continuing a rise since Friday amid broader market movements and easing inflation concerns, despite earlier pulling back from session highs.

24.07.2026 г., 21:31 ч. UTC

News

Embecta Corp is facing a securities class action lawsuit for allegedly misleading investors about its fiscal results, contributing to lower after-market hours trading.

22.07.2026 г., 18:02 ч. UTC

News

Embecta Corp shares are lower today amid a securities fraud class action lawsuit filed by Levi & Korsinsky, LLP, targeting misrepresentation of financial health.

21.07.2026 г., 23:01 ч. UTC

Embecta Corp shares are higher in after-market trading, reflecting a strong position above its 20-day moving average and near the upper end of its one-month range.

20.07.2026 г., 19:52 ч. UTC

Embecta Corp shares are rising sharply, reaching the upper end of their one-month range amid positive broader market sentiment, particularly from Asian markets.

Сравнение с други в отрасъла

Ценова промяна

Embecta Corp Прогноза

Ценова цел

By TipRanks

-14.29% надолу

12-месечна прогноза

Среден 3 USD  -14.29%

Висок 3 USD

Нисък 3 USD

Според 2 анализатори от Wall Street, предложили 12-месечна ценова цел за Embecta Corp през последните три месеца.

Консенсусна оценка

By TipRanks

Продай

2 ratings

0

Купи

1

Задържане

1

Продай

Настроение

By Acuity

308 / 340 Класиране в Здравеопазване

Настроения в новините

Мечи доказателства

Волатилност

Под средното

Обем новини (RCV)

Под средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Embecta Corp

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
help-icon Live chat